Infinitopes Precision Immunomics
- Biotech or pharma, animal health
Infinitopes is a pioneering biotech spinout from the University of Oxford, launched with support from CRUK, we are unlocking the full potential of the immune system to combat cancer metastases. By combining breakthrough, de novo antigen discovery platforms with innovative high efficiency vectors and strategically intelligent clinical trial design, Infinitopes is transforming the landscape of cancer immunotherapy.
Our mission is bold and clear: to dramatically extend and improve the lives of patients by developing truly targeted, next-generation immune medicines.